Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 35.71 -1.14%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Total Current Liabilities 2011-2024 | SUPN

Annual Total Current Liabilities Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
688 M 315 M 245 M 161 M 161 M 123 M 80.7 M 56.9 M 27.5 M 26.4 M 23 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
688 M 23 M 173 M